News

A new era for diabetes technology training

Cure for type 1 diabetes and key results of the dt-report.

Time in tight range, vision for AID, and obesity management.

Key innovations, screening, and fully-closed loop approaches.

Harmonising recommendations on the management of hyperglycaemic crises

In 1974, the International Society for Pediatric and Adolescent Diabetes (ISPAD) was founded as a professional organisation to promote science, research, education and advocacy in childhood and adolescent di...

Cardiologists are increasingly interested in advances in diabetology, especially the latest drug classes, reports Tina Vilsbøll from a joint session of the European Association for the Study of Diabet...

The global burden of diabetes is continually growing, which calls for enhanced collective action to prevent and treat diabetes complications. The Sri Lanka College of Endocrinology, the European Association ...

People living with diabetes have to make hundreds of decisions each day to manage their disease. Diabetes technology promises to ease this burden, but how effective is it in practice? This was one of the que...

The final day of the 84th ADA Scientific Sessions has arrived. In our final Newsflash episode, Alice Cheng reviews major advances and discoveries in diabetes in the year gone by.

Incretin-based therapies are our focus in the Day 3 Newsflash from the 84th ADA Scientific Sessions. Ildiko Lingvay discusses their role in preventing the progression from prediabetes to diabetes. Michael Na...

A priority to focus on in people with newly diagnosed type 2 diabetes is remission, says Roy Taylor in the Newsflash from Day 2 of the ADA Scientific Sessions, emphasising the current international consensus.

The EASD e-Learning Newsflash is back, bringing you highlights from the 84th ADA Scientific Session.

While obesity is regarded a major risk factor for the development of type 2 diabetes, the causality of the association remains debated. With current therapies targeting both obesity and diabetes, the exchang...

More than half of all men with diabetes have impaired sexual health, most commonly due to erectile dysfunction. In women with diabetes, sexual dysfunction is less prevalent, but still occurs. In a joint sess...

Challenges for people with t1d doing sports and access to diabetes tech in lower income countries were some of the focus topics on the final day of ATTD2024. Julia Mader sums up her impressions from the conf...

We focus on Chantal Mathieu’s update on CGM derived data in weekly insulins in our newsflash from #ATTD2024 Day 3. Another standout moment for us was the EUDF joint session. It explored how artificial intell...

Day 2 of ATTD 2024 came with updates on hypoglycaemia with Prof Pratik Choudhary and the unveiling of new monitoring guidance for presymptomatic type 1 diabetes with Co-Ch...

Highlights from Day1 of the 17th Conference on Advanced Technologies and Treatments for Diabetes with Prof Melanie Davies and Renza Scibilia.

‘Epidemiologic trends and disparities in diabetes risk factors among LGBTQ+ populations’ was the title of a presentation at the 59th Annual Meeting of the EASD and it highlighted the need for mor...

There is increasing interest in the role of the microbiome in many areas of medicine, including diabetes, in the hope of discovering novel therapeutic applications. A symposium at the 59th Annual Meeting of ...